BN Business News
Add your company to Business Communicator →

Energy & environment · 04/11/20261 min read

Opinion/decision on a plan of investigation for paediatrics (PIP): Tremfya, Guselkumab, type of decision: PM: decision on the application for modification of an agreed PIP, therapeutic area: gastrointestinal disorders;Gastroentology-Hepatology, number of PIP: EMA/PE/0000249046

Summary

Opinion/decision on a PIP: Tremfya, Guselkumab, type of decision: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal...

Original source language: EMA — Paediatric Investigation PlansOpen original release →

Explore insights

Business insights →